Login Register Cart 0
Generic placeholder image

Cardiovascular & Hematological Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5257
ISSN (Online): 1875-6182

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Mini-Review Article

Herbal Medicine- A Friend or a Foe of Cardiovascular Disease

Author(s): Harmanjit Kaur, Samneet Singh, Sai G. Kanagala, Vasu Gupta*, Meet A. Patel and Rohit Jain

Volume 22, Issue 2, 2024

Published on: 02 October, 2023

Page: [101 - 105] Pages: 5

DOI: 10.2174/0118715257251638230921045029

Price: $65

conference banner
Abstract

Background: Herbal remedies are used by 80% of the Asian population in primary health care as per WHO. According to current research, the herbal medicine market was valued at nearly USD 166 billion in 2021 and is expected to reach approximately USD 348 billion by 2028. Increased incidence of chronic conditions such as diabetes, asthma, coronary artery disease, osteoarthritis, has fueled the growing interest in traditional herbal and plant-derived treatments among researchers. In addition, rural communities in developing nations have renewed interest in herbal treatments due to lower cost and easy availability.

Objectives: Aim of the paper is to highlight the role of five of more commonly used herbal medicines that are Ginkgo biloba, Garlic, Flaxseed, Ginseng, Salvia miltiorrhiza in cardiovascular disorders.

Methods: A PubMed search was done using the keywords Herbal Medicine, Ginkgo biloba, Garlic, Flaxseed, Ginseng, Salvia miltiorrhiza. Articles which were available for free access were utilized. No formula inclusion or exclusion criteria was followed. A total of 42 papers were included for the study.

Conclusion: Although there have been encouraging outcomes with the use of these herbal medications, many of these products are poorly monitored and are yet to be studied in detail regarding their adverse effects. Moreover, these medicinal products are known to interact with various drugs. To compete with the expanding pharmaceutical industry, more medicinally helpful herbal items must be used and scientifically validated.

Next »
Graphical Abstract

[1]
Kaufman, D.W.; Kelly, J.P.; Rosenberg, L.; Anderson, T.E.; Mitchell, A.A. Recent patterns of medication use in the ambulatory adult population of the United States: The Slone survey. JAMA, 2002, 287(3), 337-344.
[http://dx.doi.org/10.1001/jama.287.3.337] [PMID: 11790213]
[2]
Tachjian, A.; Maria, V.; Jahangir, A. Use of herbal products and potential interactions in patients with cardiovascular diseases. J. Am. Coll. Cardiol., 2010, 55(6), 515-525.
[http://dx.doi.org/10.1016/j.jacc.2009.07.074] [PMID: 20152556]
[3]
Pınar, N. Herbal supplement usage in cardiac patients. Turk Kardiyol. Dern. Ars., 2017, 45(7), 614-622.
[http://dx.doi.org/10.5543/tkda.2017.79160]
[4]
Ernst, E. Cardiovascular adverse effects of herbal medicines: A systematic review of the recent literature. Can. J. Cardiol., 2003, 19(7), 818-827.
[PMID: 12813616]
[5]
Gücük İpek, E.; Güray, Y.; Demirkan, B.; Güray, U.; Kafes, H.; Başyiğit, F. The prevalence of alternative herbal medicine and nutritional complementary product intake in patients admitted to out-patient cardiology departments. Turk Kardiyol. Dern. Ars., 2013, 41(3), 218-224.
[http://dx.doi.org/10.5543/tkda.2013.15146] [PMID: 23703557]
[6]
Vora, C.K.; Mansoor, G.A. Herbs and alternative therapies: Relevance to hypertension and cardiovascular diseases. Curr. Hypertens. Rep., 2005, 7(4), 275-280.
[http://dx.doi.org/10.1007/s11906-005-0025-0] [PMID: 16061046]
[7]
Wood, M.J.; Stewart, R.L.; Merry, H.; Johnstone, D.E.; Cox, J.L. Use of complementary and alternative medical therapies in patients with cardiovascular disease. Am. Heart J., 2003, 145(5), 806-812.
[http://dx.doi.org/10.1016/S0002-8703(03)00084-X] [PMID: 12766736]
[8]
Jiang, R.W.; Lau, K.M.; Hon, P.M.; Mak, T.; Woo, K.S.; Fung, K.P. Chemistry and biological activities of caffeic acid derivatives from Salvia miltiorrhiza. Curr. Med. Chem., 2005, 12(2), 237-246.
[http://dx.doi.org/10.2174/0929867053363397] [PMID: 15638738]
[9]
Su, C.Y.; Ming, Q.L.; Rahman, K.; Han, T.; Qin, L.P. Salvia miltiorrhiza: Traditional medicinal uses, chemistry, and pharmacology. Chin. J. Nat. Med., 2015, 13(3), 163-182.
[http://dx.doi.org/10.1016/S1875-5364(15)30002-9] [PMID: 25835361]
[10]
Yin, Z.; Wang, X.; Yang, X.; Chen, Y.; Duan, Y.; Han, J. Salvia miltiorrhiza in anti-diabetic angiopathy. Curr. Mol. Pharmacol., 2021, 14(6), 960-974.
[http://dx.doi.org/10.2174/1874467214999210111222918] [PMID: 33430756]
[11]
Wang, L.; Ma, R.; Liu, C.; Liu, H.; Zhu, R.; Guo, S. Salvia Miltiorrhiza: A potential red light to the development of cardiovascular diseases. Curr. Pharm. Des., 2017, 23(7), 1077-1097.
[http://dx.doi.org/10.2174/1381612822666161010105242]
[12]
Wu, W.; Wang, Y. Pharmacological actions and therapeutic applications of Salvia miltiorrhiza depside salt and its active components. Acta Pharmacol. Sin., 2012, 33(9), 1119-1130.
[http://dx.doi.org/10.1038/aps.2012.126] [PMID: 22941285]
[13]
Saleem, S.; Zhuang, H.; Biswal, S.; Christen, Y.; Doré, S. Ginkgo biloba extract neuroprotective action is dependent on heme oxygenase 1 in ischemic reperfusion brain injury. Stroke, 2008, 39(12), 3389-3396.
[http://dx.doi.org/10.1161/STROKEAHA.108.523480] [PMID: 18845796]
[14]
Diamond, B.J.; Bailey, M.R. Ginkgo biloba. Psychiatr. Clin. North Am., 2013, 36(1), 73-83.
[http://dx.doi.org/10.1016/j.psc.2012.12.006] [PMID: 23538078]
[15]
Kuller, L.H.; Ives, D.G.; Fitzpatrick, A.L.; Carlson, M.C.; Mercado, C.; Lopez, O.L.; Burke, G.L.; Furberg, C.D.; DeKosky, S.T. Does Ginkgo biloba reduce the risk of cardiovascular events? Circ. Cardiovasc. Qual. Outcomes, 2010, 3(1), 41-47.
[http://dx.doi.org/10.1161/CIRCOUTCOMES.109.871640] [PMID: 20123670]
[16]
Tian, J.; Liu, Y.; Chen, K. Ginkgo biloba extract in vascular protection: Molecular Mechanisms and Clinical Applications. Curr. Vascul. Pharmacol., 2017, 15(6), 532-548.
[17]
Auguet, M.; Delaflotte, S.; Hellegouarch, A.; Clostre, F. Pharmacological bases of the vascular impact of Ginkgo biloba extract. Presse Med., 1986, 15(31), 1524-1528.
[PMID: 2947093]
[18]
Cohen, A.J.; Bartlik, B. Ginkgo biloba for antidepressant-induced sexual dysfunction. J. Sex Marital Ther., 1998, 24(2), 139-143.
[http://dx.doi.org/10.1080/00926239808404927] [PMID: 9611693]
[19]
Roland, P-D; Nergård, C Ginkgo biloba - effect, side effects and interactions. Tidsskrift for Den norske legeforening, 2012, 132(8), 956-959.
[20]
Bent, S.; Goldberg, H.; Padula, A.; Avins, A.L. Spontaneous bleeding associated with Ginkgo biloba. J. Gen. Intern. Med., 2005, 20(7), 657-661.
[http://dx.doi.org/10.1007/s11606-005-0114-4] [PMID: 16050865]
[21]
Kajla, P.; Sharma, A.; Sood, D-R. Flaxseed-a potential functional food source. J. Food Sci. Technol., 2014, 52(4), 1857-1871.
[22]
Rodriguez-Leyva, D.; Weighell, W.; Edel, A.L.; LaVallee, R.; Dibrov, E.; Pinneker, R.; Maddaford, T.G.; Ramjiawan, B.; Aliani, M.; Guzman, R.; Pierce, G.N. Potent antihypertensive action of dietary flaxseed in hypertensive patients. Hypertension, 2013, 62(6), 1081-1089.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.113.02094] [PMID: 24126178]
[23]
Parikh, M.; Netticadan, T.; Pierce, G-N. Flaxseed: Its bioactive components and their cardiovascular benefits. Am. J. Physiology-Heart Circulatory Physiol., 2018, 314(2), H146-H159.
[24]
Edel, A.L.; Rodriguez-Leyva, D.; Maddaford, T.G.; Caligiuri, S.P.B.; Austria, J.A.; Weighell, W. Dietary flaxseed independently lowers circulating cholesterol and lowers it beyond the effects of cholesterol-lowering medications alone in patients with peripheral artery disease. J. Nutr., 2015, 145(4), 749-757.
[http://dx.doi.org/10.3945/jn.114.204594]
[25]
Barakat, L.; Mahmoud, R. The antiatherogenic, renal protective and immunomodulatory effects of purslane, pumpkin and flax seeds on hypercholesterolemic rats. N. Am. J. Med. Sci., 2011, 3(9), 411-417.
[http://dx.doi.org/10.4297/najms.2011.3411] [PMID: 22362450]
[26]
Bayan, L.; Koulivand, P.H.; Gorji, A. Garlic: A review of potential therapeutic effects. Avicenna J. Phytomed., 2014, 4(1), 1-14.
[PMID: 25050296]
[27]
El-Saber Batiha, G.; Magdy Beshbishy, A.; G Wasef, L.; Elewa, Y.H.A.; A Al-Sagan, A.; Abd El-Hack, M.E.; Taha, A.E.; M Abd-Elhakim, Y.; Prasad Devkota, H. Chemical constituents and pharmacological activities of garlic (allium sativum L.): A review. Nutrients, 2020, 12(3), 872.
[http://dx.doi.org/10.3390/nu12030872] [PMID: 32213941]
[28]
Rahman, K.; Lowe, G.M. Garlic and cardiovascular disease: A critical review. J. Nutr., 2006, 136(3), 736S-740S.
[http://dx.doi.org/10.1093/jn/136.3.736S] [PMID: 16484553]
[29]
Sobenin, I.A.; Myasoedova, V.A.; Iltchuk, M.I.; Zhang, D.W.; Orekhov, A.N. Therapeutic effects of garlic in cardiovascular atherosclerotic disease. Chin. J. Nat. Med., 2019, 17(10), 721-728.
[http://dx.doi.org/10.1016/S1875-5364(19)30088-3] [PMID: 31703752]
[30]
Rashid, A.; Khan, H.H. The mechanism of hypotensive effect of garlic extract. J. Pak. Med. Assoc., 1985, 35(12), 357-362.
[PMID: 3937909]
[31]
De Greef, D.; Barton, E.M.; Sandberg, E.N.; Croley, C.R.; Pumarol, J.; Wong, T.L.; Das, N.; Bishayee, A. Anticancer potential of garlic and its bioactive constituents: A systematic and comprehensive review. Semin. Cancer Biol., 2021, 73, 219-264.
[http://dx.doi.org/10.1016/j.semcancer.2020.11.020] [PMID: 33301861]
[32]
Capasso, A. Antioxidant action and therapeutic efficacy of allium sativum L. Molecules, 2013, 18(1), 690-700.
[33]
Bhatwalkar, S.B.; Mondal, R.; Krishna, S.B.N.; Adam, J.K.; Govender, P.; Anupam, R. Antibacterial properties of organosulfur compounds of garlic (allium sativum). Front. Microbiol., 2021, 12, 613077.
[http://dx.doi.org/10.3389/fmicb.2021.613077] [PMID: 34394014]
[34]
Tattelman, E. Health effects of garlic. Am. Fam. Physician, 2005, 72(1), 103-106.
[PMID: 16035690]
[35]
Mancuso, C.; Santangelo, R. Panax ginseng and Panax quinquefolius: From pharmacology to toxicology. Food Chem. Toxicol., 2017, 107(Pt A), 362-372.
[http://dx.doi.org/10.1016/j.fct.2017.07.019] [PMID: 28698154]
[36]
Kiefer, D.; Pantuso, T. Panax ginseng. Am. Fam. Physician, 2003, 68(8), 1539-1542.
[PMID: 14596440]
[37]
Coon, J.T.; Ernst, E. Panax ginseng. Drug Saf., 2002, 25(5), 323-344.
[http://dx.doi.org/10.2165/00002018-200225050-00003] [PMID: 12020172]
[38]
Wang, C.Z.; Anderson, S.; Du, W.; He, T.C.; Yuan, C.S. Red ginseng and cancer treatment. Chin. J. Nat. Med., 2016, 14(1), 7-16.
[http://dx.doi.org/10.1186/s13020-019-0231-3] [PMID: 26850342]
[39]
Wang, L.; Huang, Y.; Yin, G.; Wang, J.; Wang, P. Chen, ZY Antimicrobial activities of Asian ginseng, American ginseng, and notoginseng. Phytother. Res., 2019, 34(6), 1226-1236.
[40]
Fan, W.; Huang, Y.; Zheng, H.; Li, S.; Li, Z.; Yuan, L.; Cheng, X.; He, C.; Sun, J. Ginsenosides for the treatment of metabolic syndrome and cardiovascular diseases: Pharmacology and mechanisms. Biomed. Pharmacother., 2020, 132, 110915.
[http://dx.doi.org/10.1016/j.biopha.2020.110915] [PMID: 33254433]
[41]
Oh, S.H.; Lee, B.H. A ginseng saponin metabolite-induced apoptosis in HepG2 cells involves a mitochondria-mediated pathway and its downstream caspase-8 activation and Bid cleavage. Toxicol. Appl. Pharmacol., 2004, 194(3), 221-229.
[http://dx.doi.org/10.1016/j.taap.2003.09.011] [PMID: 14761678]
[42]
Huang, X.; Li, N.; Pu, Y.; Zhang, T.; Wang, B. Neuroprotective effects of ginseng phytochemicals: Recent perspectives. Molecules, 2019, 24(16), 2939.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy